Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dulera coupons discounts?Cost of teriflunomide?Caverject alternatives?Which cancer type first gained keytruda's approval?Dulera 100 mcg 5 mcg inhaler price?
See the DrugPatentWatch profile for Cilostazol
Cilostazol is prescribed to improve walking ability in people with intermittent claudication due to peripheral artery disease (PAD). It is used to help increase the distance a person can walk before pain starts.
Clinicians most commonly use cilostazol for adults with PAD who have intermittent claudication, meaning they get leg pain with walking that improves with rest.
Cilostazol’s key labeled indication is for improving symptoms of intermittent claudication from PAD. Uses outside that indication depend on local prescribing practices and evidence, but the core indication is symptom improvement in PAD.
Cilostazol can be unsuitable for some patients, especially those with heart failure. Patients with relevant cardiac conditions should discuss risks and alternatives with their clinician before starting it.
When it works for PAD-related intermittent claudication, people typically report being able to walk longer before leg pain begins, compared with baseline. Improvement may take some time rather than being immediate.
Other Questions About Cilostazol :